Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2010-02-16 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT RAPHAEL (83530), Var
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DU NOUVEAU GOLF : revenue, balance sheet and financial ratios
SELARL PHARMACIE DU NOUVEAU GOLF is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT RAPHAEL (83530),
this company of category PME
shows in 2025 a net income positive of 140 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DU NOUVEAU GOLF (SIREN 520318007)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
140 334 €
223 751 €
264 717 €
339 436 €
130 554 €
142 047 €
117 942 €
103 261 €
71 258 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELARL PHARMACIE DU NOUVEAU GOLF generates positive net income of 140 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 71 k€ -> 140 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
140 334 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 78%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
4.055%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
77.697%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DU NOUVEAU GOLF
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
230.127
177.304
128.609
90.641
60.661
28.907
12.856
5.331
4.055
Financial autonomy
24.556
29.313
35.492
41.245
47.947
58.853
68.312
79.445
77.697
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
4.052025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Excellent
In 2025, the debt ratio of SELARL PHARMACIE DU NOUVE... (4.05) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
77.7%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Excellent
In 2025, the financial autonomy of SELARL PHARMACIE DU NOUVE... (77.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 135.38. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
135.377
Liquidity indicators evolution SELARL PHARMACIE DU NOUVEAU GOLF
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
90.254
86.681
75.371
72.51
60.57
83.985
95.243
120.657
135.377
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
135.382025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average+9 pts over 3 years
In 2025, the liquidity ratio of SELARL PHARMACIE DU NOUVE... (135.38) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SELARL PHARMACIE DU NOUVEAU GOLF in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE DU NOUVEAU GOLF is estimated at
2 229 222 €
(range 1 512 760€ - 3 497 956€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1512k€2229k€3497k€
2 229 222 €Range: 1 512 760€ - 3 497 956€
NAF 5 année 2025
Valuation method used
Net Income Multiple
140 334 €
×
15.9x
=2 229 222 €
Range: 1 512 761€ - 3 497 957€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DU NOUVEAU GOLF with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DU NOUVEAU GOLF
What is the revenue of SELARL PHARMACIE DU NOUVEAU GOLF ?
The revenue of SELARL PHARMACIE DU NOUVEAU GOLF is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE DU NOUVEAU GOLF profitable?
Yes, SELARL PHARMACIE DU NOUVEAU GOLF generated a net profit of 140 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE DU NOUVEAU GOLF ?
The headquarters of SELARL PHARMACIE DU NOUVEAU GOLF is located in SAINT RAPHAEL (83530), in the department Var.
Where to find the tax return of SELARL PHARMACIE DU NOUVEAU GOLF ?
The tax return of SELARL PHARMACIE DU NOUVEAU GOLF is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DU NOUVEAU GOLF operate?
SELARL PHARMACIE DU NOUVEAU GOLF operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart